Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 421

1.

Comparison of integrated traditional Chinese and western medicine therapy on vascular cognitive impairment with no dementia.

Wang LP, Zhang XY, Liu N, Ma ZZ, Fang DS.

Genet Mol Res. 2015 May 11;14(2):4896-902. doi: 10.4238/2015.May.11.22.

PMID:
25966264
2.

Demenz vom Alzheimer-Typ: Nicht-medikamentöse und medikamentöse Therapie.

Kressig RW.

Ther Umsch. 2015 Apr;72(4):233-8. doi: 10.1024/0040-5930/a000670. German.

PMID:
25791046
3.

Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders.

Montes P, Ruiz-Sanchez E, Rojas C, Rojas P.

CNS Neurol Disord Drug Targets. 2015;14(1):132-49.

PMID:
25642989
4.

Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.

Liu X, Hao W, Qin Y, Decker Y, Wang X, Burkart M, Schötz K, Menger MD, Fassbender K, Liu Y.

Brain Behav Immun. 2015 May;46:121-31. doi: 10.1016/j.bbi.2015.01.011. Epub 2015 Jan 28.

PMID:
25637484
5.

Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.

Gauthier S, Schlaefke S.

Clin Interv Aging. 2014 Nov 28;9:2065-77. doi: 10.2147/CIA.S72728. eCollection 2014.

6.

Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract.

Heinonen T, Gaus W.

Toxicology. 2015 Jan 2;327:95-115. doi: 10.1016/j.tox.2014.10.013. Epub 2014 Nov 11.

7.

EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.

Wan WB, Cao L, Liu LM, Kalionis B, Chen C, Tai XT, Li YM, Xia SJ.

PLoS One. 2014 Nov 26;9(11):e113126. doi: 10.1371/journal.pone.0113126. eCollection 2014.

8.
9.

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.

Lopez OL, Klunk WE, Mathis C, Coleman RL, Price J, Becker JT, Aizenstein HJ, Snitz B, Cohen A, Ikonomovic M, McDade E, DeKosky ST, Weissfeld L, Kuller LH.

Neurology. 2014 Nov 11;83(20):1804-11. doi: 10.1212/WNL.0000000000000977. Epub 2014 Oct 10.

PMID:
25305156
10.

Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.

Tan MS, Yu JT, Tan CC, Wang HF, Meng XF, Wang C, Jiang T, Zhu XC, Tan L.

J Alzheimers Dis. 2015;43(2):589-603. doi: 10.3233/JAD-140837.

PMID:
25114079
11.

A systematic review on natural medicines for the prevention and treatment of Alzheimer's disease with meta-analyses of intervention effect of ginkgo.

Yang M, Xu DD, Zhang Y, Liu X, Hoeven R, Cho WC.

Am J Chin Med. 2014;42(3):505-21. doi: 10.1142/S0192415X14500335. Review.

PMID:
24871648
12.

Author Response.

Yasar S, Furberg C, Kawas C, Carlson M.

Neurology. 2014 Apr 1;82(13):1192-3. No abstract available.

PMID:
24812674
13.
14.

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

Kalra L.

Neurology. 2014 Apr 1;82(13):1192. doi: 10.1212/WNL.0000000000000231. No abstract available.

PMID:
24688098
15.

Apathy in Alzheimer's disease: any effective treatment?

Rea R, Carotenuto A, Fasanaro AM, Traini E, Amenta F.

ScientificWorldJournal. 2014 Feb 2;2014:421385. doi: 10.1155/2014/421385. eCollection 2014. Review.

16.

Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.

Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group.

Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16.

17.

Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells.

Yang YH, Hsieh TJ, Tsai ML, Chen CH, Lin HT, Wu SJ.

J Nutr Health Aging. 2014;18(2):184-90. doi: 10.1007/s12603-013-0382-3.

PMID:
24522472
18.

Phytochemical and medicinal importance of Ginkgo biloba L.

Mohanta TK, Tamboli Y, Zubaidha PK.

Nat Prod Res. 2014;28(10):746-52. doi: 10.1080/14786419.2013.879303. Epub 2014 Feb 5. Review.

PMID:
24499319
19.

Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany.

Czeche S, Schüssel K, Franzmann A, Burkart M, Schulz M.

BMC Complement Altern Med. 2013 Oct 24;13:278. doi: 10.1186/1472-6882-13-278.

20.

Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.

Hughes TM, Kuller LH, Barinas-Mitchell EJ, Mackey RH, McDade EM, Klunk WE, Aizenstein HJ, Cohen AD, Snitz BE, Mathis CA, Dekosky ST, Lopez OL.

Neurology. 2013 Nov 5;81(19):1711-8. doi: 10.1212/01.wnl.0000435301.64776.37. Epub 2013 Oct 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk